Strategies to direct angiogenesis within scaffolds for bone tissue engineering
Greg M Harris1, Katy Rutledge, Qingsu Cheng
1Department of Chemical Engineering, University of South Carolina, Columbia, SC 29208, USA. ehsan@sc.edu.
Current Pharmaceutical Design
|February 26, 2013
Summary
Orthopaedic bone grafting faces challenges with scaffold vascularization. This review explores natural bone and vessel formation, microenvironmental cues, and fabrication techniques to improve vascularized bone tissue engineering for clinical use.
Area of Science:
- Orthopaedic tissue engineering
- Biomaterials science
- Regenerative medicine
Background:
- Significant need for effective orthopaedic grafting strategies due to trauma and musculoskeletal diseases.
- Current bone tissue engineering approaches are hindered by inadequate vascularization of implanted scaffolds, limiting clinical translation.
- Vascularization is critical for the survival and integration of engineered bone grafts.
Purpose of the Study:
- To review natural bone and vessel formation processes relevant to tissue engineering.
- To explore microenvironmental cues that influence vascularization in engineered bone scaffolds.
- To discuss microscale fabrication techniques for coordinating bone and vessel development for improved graft success.
Main Methods:
- Literature review of natural osteogenesis and angiogenesis.
- Analysis of signaling pathways and cellular interactions in bone and vessel development.
- Examination of microfabrication techniques for scaffold design and vascularization strategies.
Main Results:
- Understanding of coupled bone and vessel development pathways is essential.
- Specific microenvironmental cues can be leveraged to promote vascularization.
- Advanced fabrication methods offer precise control over scaffold architecture and cell distribution.
Conclusions:
- Coordinated vascularization is a key bottleneck in bone tissue engineering.
- Integrating knowledge of natural development with advanced fabrication is crucial for clinical success.
- Future strategies should focus on biomimetic approaches to vascularize engineered bone grafts.
More Related Videos
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...


